Safety and Efficacy of SYHA1813 Single Agent or in Combination With Different Regimens in Unresectable Locally Advanced or Metastatic Solid Tumors.
Clinical trial NCT06682611 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06682611
- Sponsor
- Shanghai Runshi Pharmaceutical Technology Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-13
- Primary completion
- 2026-11-13
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.